Download
s00066-021-01853-7.pdf 508,99KB
WeightNameValue
1000 Titel
  • Risk stratification by anamnesis increases SARS-CoV-2 test efficiency in cancer patients
1000 Autor/in
  1. Arnold, Christian Cornelius |
  2. von der Grün, Jens |
  3. Brekner, Mark Christoph |
  4. Licher, Jörg |
  5. Fokas, Emmanouil |
  6. Rödel, Claus |
  7. Fleischmann, Maximilian |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-10-07
1000 Erschienen in
1000 Quellenangabe
  • 198(4):354-360
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00066-021-01853-7 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494759/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!To evaluate the impact of testing asymptomatic cancer patients, we analyzed all tests for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) before and during radiotherapy at a tertiary cancer center throughout the second wave of the pandemic in Germany.!##!Methods!#!Results of all real-time polymerase chain reaction (RT-PCR) tests for SARS-CoV‑2 performed at our radio-oncology department between 13 October 2020 and 11 March 2021 were included. Clinical data and anamnestic information at the time of testing were documented and examined for (i) the presence of COVID-19-related symptoms and (ii) virus-related anamnesis (high-risk [prior positive test or contact to a positive tested person within the last 14 days] or low-risk [inconspicuous anamnesis within the last 14 days]).!##!Results!#!A total of 1056 SARS-CoV‑2 tests in 543 patients were analyzed. Of those, 1015 tests were performed in asymptomatic patients and 41 tests in patients with COVID-19-associated symptoms. Two of 940 (0.2%) tests in asymptomatic patients with low-risk anamnesis and three of 75 (4.0%) tests in asymptomatic patients with high-risk anamnesis showed a positive result. For symptomatic patients, SARS-CoV‑2 was detected in three of 36 (8.3%) low-risk and three of five (60.0%) high-risk tests.!##!Conclusion!#!To the best of our knowledge, this is the first study evaluating the correlation between individual risk factors and positivity rates of SARS-CoV‑2 tests in cancer patients. The data demonstrate that clinical and anamnestic assessment is a simple and effective measure to distinctly increase SARS-CoV‑2 test efficiency. This might enable cancer centers to adjust test strategies in asymptomatic patients, especially when test resources are scarce.
1000 Sacherschließung
lokal COVID-19/diagnosis [MeSH]
gnd 1206347392 COVID-19
lokal Radiation Oncology
lokal COVID-19 Nucleic Acid Testing [MeSH]
lokal Humans [MeSH]
lokal COVID-19
lokal Germany/epidemiology [MeSH]
lokal Pandemics [MeSH]
lokal Original Article
lokal SARS-CoV-2/isolation
lokal Neoplasms/radiotherapy [MeSH]
lokal SARS-CoV‐2 testing
lokal Real-time polymerase chain reaction (PCR) tests
lokal Risk Assessment/methods [MeSH]
lokal COVID-19/epidemiology [MeSH]
lokal Radiotherapy
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/QXJub2xkLCBDaHJpc3RpYW4gQ29ybmVsaXVz|https://frl.publisso.de/adhoc/uri/dm9uwqBkZXLCoEdyw7xuLCBKZW5z|https://frl.publisso.de/adhoc/uri/QnJla25lciwgTWFyayBDaHJpc3RvcGg=|https://frl.publisso.de/adhoc/uri/TGljaGVyLCBKw7ZyZw==|https://frl.publisso.de/adhoc/uri/Rm9rYXMsIEVtbWFub3VpbA==|https://frl.publisso.de/adhoc/uri/UsO2ZGVsLCBDbGF1cw==|https://frl.publisso.de/adhoc/uri/RmxlaXNjaG1hbm4sIE1heGltaWxpYW4=
1000 Hinweis
  • DeepGreen-ID: 175707308eab4505b06f3c01fccc651a ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6448571.rdf
1000 Erstellt am 2023-05-03T18:51:12.957+0200
1000 Erstellt von 322
1000 beschreibt frl:6448571
1000 Zuletzt bearbeitet 2023-10-20T22:57:07.679+0200
1000 Objekt bearb. Fri Oct 20 22:57:07 CEST 2023
1000 Vgl. frl:6448571
1000 Oai Id
  1. oai:frl.publisso.de:frl:6448571 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source